EVLV Q4 2025: 32% Revenue Growth Anchored by Direct Fulfillment Shift and Expanding Recurring Base
Evolve Technology’s Q4 results spotlight a pivotal shift to direct fulfillment, fueling strong revenue growth and a more durable recurring revenue base. The company’s hardware-enabled subscription model is driving deeper customer adoption across education, healthcare, and enterprise segments, while operational leverage and a robust backlog set the stage for accelerated ARR growth in 2026. Investors should watch for margin trends and regulatory tailwinds as Evolve scales its platform and transitions manufacturing to Plexus.
Summary
- Direct Fulfillment Model Drives Revenue Visibility: Evolve’s transition to in-house fulfillment is reshaping revenue mix and boosting recurring revenue durability.
- Customer Expansion and Product Attach Rates Accelerate: New and existing customers are increasingly adopting multi-product solutions, deepening platform stickiness.
- 2026 Outlook Raised on Pipeline Strength: Upbeat guidance reflects strong backlog, regulatory catalysts, and operational improvements.
Performance Analysis
Evolve Technology’s Q4 2025 performance was defined by a 32% year-over-year revenue increase, underpinned by a strategic shift to direct fulfillment of purchase subscriptions. This move allowed the company to capture more revenue and gross profit dollars per contract, albeit with near-term margin tradeoffs. For the full year, revenue growth reached 40%, driven by robust customer acquisition, expansion within existing accounts, and a $15 million uplift from direct hardware fulfillment. The recurring revenue engine gained momentum, with annual recurring revenue (ARR) up 21% year-over-year and remaining performance obligation (RPO) climbing 13% to $293.4 million, signaling growing forward visibility.
Adjusted EBITDA margin improved substantially, with the company delivering its fifth consecutive quarter of positive EBITDA and a full-year margin of 7.6%—a swing of $32 million from the prior year’s loss. Cash generation was strong in Q4, with cash, equivalents, and marketable securities rising $12.8 million sequentially. Operational discipline was evident in expense control, as adjusted operating expenses grew just 3% versus 32% revenue growth, reinforcing the scalability of Evolve’s hardware-enabled SaaS model.
- Revenue Mix Shift: Direct fulfillment of purchase subscriptions increased near-term revenue and gross profit dollars but pressured gross margin percentage, as planned.
- Operational Leverage: Expense growth trailed revenue, highlighting margin expansion potential as the business scales.
- Cash Flow Strength: Q4 cash collections were robust, though management cautioned that some drivers were non-recurring.
The combination of a growing installed base, multi-year subscription contracts, and disciplined cost management signals a maturing business model with increasing predictability and operating leverage.
Executive Commentary
"We are unique. We use a tight combination of hardware, sensors, proprietary data sets, and software that enables our AI models to make rapid decisions at customer locations. We control our full solution stack."
John Kaczorski, President and Chief Executive Officer
"Adjusted gross margin was 50% in Q4 compared to 62% in the same period last year. The shift to direct fulfillment of our purchase subscription orders creates near-term gross margin headwind. This dynamic is exactly what we planned for... the direct model delivers higher gross profit dollars over the life of the contract."
Chris Kutzer, Chief Financial Officer
Strategic Positioning
1. Hardware-Enabled SaaS Moat
Evolve’s end-to-end solution stack—combining proprietary hardware, AI-driven software, and unique data—creates a defensible moat against pure software competitors. The company’s ability to leverage real-world data from thousands of deployed systems underpins continuous model improvement and differentiation in threat detection. This integrated approach enables Evolve to monetize its platform through multi-year, recurring subscription contracts, supporting ARR and RPO growth.
2. Multi-Segment Expansion and Regulatory Tailwinds
Growth is broad-based across education, healthcare, sports/entertainment, and workplace verticals. Notably, regulatory momentum in states like California (mandating advanced weapons screening in schools by 2027) and emerging legislation in Georgia are creating structural demand tailwinds. The new partnership with the American Hospital Association (AHA) positions Evolve as a preferred provider to nearly 5,000 hospitals, expanding reach in a sector facing acute security challenges.
3. Product Portfolio Deepening and Attach Rates
The launch and rapid adoption of Expedite, Evolve’s AI-based bag screening solution, is boosting multi-product attach rates and customer stickiness. In Q4, 16 new customers purchased Expedite, with most also adopting Express, lowering average customer acquisition costs and driving platform expansion. Early deployments show lower false alarm rates and operational efficiency, supporting further cross-sell and upsell opportunities.
4. Operational Scale and Manufacturing Transition
The upcoming transition to Plexus as contract manufacturer is on track for the second half of 2026. Management anticipates this will provide gross margin tailwinds and working capital efficiencies, further enhancing operational leverage as the installed base surpasses 10,000 units.
5. Pricing and Fulfillment Model Evolution
Recent changes to pricing—lower upfront hardware cost, higher software and services pricing—are expected to accelerate ARR growth, particularly as the mix shifts toward higher-value subscriptions. This evolution is designed to drive higher ARR per unit and improve long-term revenue quality.
Key Considerations
This quarter marked a strategic inflection as Evolve’s business model matured, with operational discipline and product innovation setting the foundation for durable growth. Management’s raised guidance and commentary indicate confidence in pipeline visibility, while regulatory and product catalysts offer additional upside.
Key Considerations:
- Mix Dynamics: Direct fulfillment of purchase subscriptions boosts revenue and gross profit dollars but temporarily pressures gross margin percentage.
- Recurring Revenue Quality: Multi-year contracts and rising attach rates are increasing the predictability and durability of revenue streams.
- Regulatory Catalysts: State mandates and AHA partnership are likely to accelerate adoption in education and healthcare verticals.
- Operational Leverage: Expense growth remains well below revenue growth, supporting ongoing margin expansion even as the company invests in R&D and sales.
- Manufacturing Transition: The Plexus ramp is expected to provide margin and working capital benefits in the back half of 2026.
Risks
Gross margin pressure remains a near-term risk as direct fulfillment model ramps and one-time service costs are absorbed. Cash flow strength in Q4 was aided by non-recurring collections, suggesting investors should monitor sustainability. Regulatory and legislative momentum is favorable, but execution risk exists in scaling deployments and maintaining product quality as volume grows. Competitive threats from new entrants and technology shifts, particularly in AI and security hardware, also warrant attention.
Forward Outlook
For Q1 2026, Evolve expects:
- Revenue growth rate in the high 30% range, driven by backlog installation and one-time product revenue uplift.
- Modest sequential revenue decline in Q2 as prior-year backlog is consumed.
For full-year 2026, management raised guidance:
- Revenue of $172 million to $178 million (previously $160 million to $165 million).
- ARR exit rate of $145 million to $150 million, up 20% to 25% year-over-year.
- Adjusted EBITDA margin expansion to high single digits.
Management highlighted several factors that will shape results:
- ARR growth is expected to accelerate as pricing changes and mix shift take hold in the back half of the year.
- Plexus manufacturing transition to drive margin and working capital improvements in H2 2026.
Takeaways
Evolve’s Q4 2025 results demonstrate a maturing business model with increasing recurring revenue visibility and operational leverage, while regulatory and product catalysts support a robust growth outlook for 2026.
- Business Model Maturation: The shift to direct fulfillment and pricing changes are structurally improving revenue quality and long-term profitability, despite near-term margin headwinds.
- Platform Expansion: Product innovation and attach rates are deepening customer relationships and unlocking new verticals, especially in healthcare and education.
- Execution Watchpoint: Investors should monitor gross margin trajectory, sustainability of cash flow, and the pace of regulatory-driven adoption as Evolve scales manufacturing and operations.
Conclusion
Evolve Technology’s Q4 capped a transformative year, with the direct fulfillment model and multi-segment expansion positioning the company for durable, high-quality growth. While near-term margin pressure and execution risks remain, the platform’s momentum and regulatory tailwinds offer significant upside as Evolve enters 2026 with a strengthened foundation.
Industry Read-Through
Evolve’s results signal a broader shift toward hardware-enabled SaaS models in physical security, where proprietary data and AI differentiation are key to recurring revenue durability. The regulatory momentum in education and healthcare verticals is likely to accelerate adoption of advanced screening technologies across the industry. Competitors and adjacent sectors should note the operational leverage and customer stickiness enabled by multi-product platforms and end-to-end control of the solution stack. As security becomes standard infrastructure in public spaces, vendors with integrated hardware, data, and software are best positioned to capture long-term market share.